Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Curex is a healthcare technology company specializing in long-term allergy relief through sublingual immunotherapy (SLIT). The company provides a telehealth platform that connects patients with clinicians for allergy testing and personalized treatment plans using under-the-tongue drops. By offering an at-home alternative to traditional allergy shots, Curex aims to make immunotherapy more accessible and convenient for the millions of people suffering from environmental and pet allergies. Their services include clinical consultation, at-home testing kits, and the delivery of customized allergen extracts. The company's model focuses on improving patient adherence to multi-year immunotherapy protocols through digital monitoring and convenient delivery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Curex.